New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]
Mar 27, 2024
27:18
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
MDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and roxodustat.
כל תכני עושים היסטוריה